Stocks
Johnson & JohnsonJNJ
NYSEHealthcarePharmaceuticals$241.52-0.21%
A diversified healthcare manufacturer focused on prescription pharmaceuticals and medical technology products used in areas such as oncology, immunology, surgery, and orthopedics. The company generates the majority of revenue from its drug portfolio while maintaining a large global medtech business ...
Market Cap: $582.0B52W Range: $141.50 – $251.71
Congressional Interest in Johnson & Johnson (JNJ)
21 members of Congress have disclosed 50 trades in Johnson & Johnson (JNJ), a Healthcare company. The buy/sell breakdown shows 24 purchases versus 26 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
21
Buys
24
Sells
26
Who in Congress Is Trading JNJ?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-03-20 | Rohit Khanna | sell | $1K – $15K |
| 2024-03-15 | MICHAEL T. MCCAUL | buy | $15K – $50K |